Back

Extravascular defibrillator in patients not suited for the subcutaneous defibrillator.

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Shocking news regarding implantable cardioverter-defibrillator therapy Implantable Cardioverter-Defibrillator (ICD) ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Andrea Quaranta

University Hospital of Bologna S. Orsola-Malpighi Polyclinic, Bologna (Italy)

7 More presentations in this session

Presentation thumbnail
Predictors of ICD therapy in cardiac sarcoidosis patients within large metropolitan population
Doctor N. Kim (New York, US) Doctor S. Daoui (New York City, US)
Abstract Slides Video
Presentation thumbnail
Head-to-head comparison of single- versus dual-chamber ICD discriminators for tachyarrhythmia detection: a remote monitoring based, bicentric study
Doctor F. Gausz (Szeged, HU)
Abstract Slides Video
Presentation thumbnail
Evaluation of defibrillation thresholds in extravascular defibrillators: results from a monocenter prospective study
Doctor A. Quaranta (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Feasibility of extravascular defibrillator implantation in a fully cardiological setting: from general anesthesia to deep sedation, and relevance of surgical back-up
Doctor A. Quaranta (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Clinical outcomes after implantable cardioverter-defibrillator therapy in patients with chronic Chagas cardiomyopathy: an updated systematic review and meta-analysis
Doctor I. Ferreira Felix (Rochester, US)
Abstract Slides Video

Access the full session

Session thumbnail
Shocking news regarding implantable cardioverter-defibrillator therapy

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Evaluation of defibrillation thresholds in extravascular defibrillators: results from a monocenter prospective study
thumbnail
Congress Presentation
Debating the future of implantable cardioverter-defibrillator therapy - extravascular implantable cardioverter-defibrillator: optimising protection while minimising risk
thumbnail
Congress Presentation
Extravascular Implantable Cardioverter Defibrillator (EV-ICD) therapy in patients with genetic heart disease: a single center experience

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources